Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.
Journal: Nature medicine
Published: May 16, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: December 26, 2024
Approved CAR-T therapies have reproducible efficacy and safety in clinical practice.
Journal: Human vaccines & immunotherapeutics
Published: August 06, 2024
Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant.
Journal: Transplantation and cellular therapy
Published: May 28, 2024
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers.
Journal: Research square
Published: April 22, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.
Journal: Nature
Published: March 14, 2024
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.
Journal: Blood
Published: January 19, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 27, 2023
Bringing CAR T cell therapy trials to underserved populations.
Journal: Cancer cell
Published: September 29, 2023
Last Updated: 09/26/2026